approval
saveSUNLENCA (LENACAPAVIR SODIUM) — FDA approval
community read0 votes
Sponsor: GILEAD SCIENCES INC. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalSUNLENCA (LENACAPAVIR SODIUM) — FDA approvalMar 12, 2026 · 206d ago
- approvalSUNLENCA (LENACAPAVIR SODIUM) — FDA approvalNov 25, 2024 · 678d ago
- approvalSUNLENCA (LENACAPAVIR SODIUM) — FDA approvalNov 25, 2024 · 678d ago
- approvalSUNLENCA (LENACAPAVIR SODIUM) — FDA approvalNov 13, 2024 · 690d ago
- approvalSUNLENCA (LENACAPAVIR SODIUM) — FDA approvalNov 13, 2024 · 690d ago
- approvalSUNLENCA (LENACAPAVIR SODIUM) — FDA approvalJul 17, 2024 · 809d ago
- approvalSUNLENCA (LENACAPAVIR SODIUM) — FDA approvalJul 17, 2024 · 809d ago
- approvalSUNLENCA (LENACAPAVIR SODIUM) — FDA approvalDec 22, 2022 · 1382d ago
same company · ±60 days · 6
- approvallenacapavir sodium LA: SUNLENCA (LENACAPAVIR SODIUM) — FDA approvalMar 12, 2026
- approvalPREZCOBIX (DARUNAVIR AND COBICISTAT) — FDA approvalFeb 27, 2026
- approvalPREZCOBIX (COBICISTAT) — FDA approvalFeb 27, 2026
- approvalseladelpar lysine: LIVDELZI (SELADELPAR LYSINE) — FDA approvalJan 30, 2026
- phase 1 initiationGS-1701: Gilead Sciences Inc — GS-1701 (Phase I Trial Initiation)Apr 30, 2026
- earningsGILEAD SCIENCES, INC. earningsMay 7, 2026
comments(0)
5-min edit window · permanent after that